FMP
INVO Bioscience, Inc.
INVO
NASDAQ
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
0.98 USD
-0.0001 (-0.0102%)
About
ceo
Mr. Steven M. Shum
sector
Healthcare
industry
Medical - Devices
website
https://www.invobio.com
exchange
NASDAQ
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
CIK
0001417926
ISIN
US44984F4019
CUSIP
44984F302
Address
5582 Broadcast Court
Phone
978 878 9505
Country
US
Employee
25
IPO Date
Nov 2, 2020
Summary
CIK
0001417926
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
44984F302
ISIN
US44984F4019
Country
US
Price
0.98
Beta
1.49
Volume Avg.
3.83M
Market Cap
2.69M
Shares
-
52-Week
0.5-10.5
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.19
P/B
-
Website
https://www.invobio.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest INVO News
It looks like there's no news available.
